Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
LENZELTA® is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers1. Administration is simple with two doses during the dry-off...
-
Aktieägarna i Virtune AB (Publ) org.nr 559175–2067, med säte i Stockholm, kallas härmed till årsstämma onsdag den 20 maj 2026 kl. 16:00. Årsstämman kommer hållas i Convendum lokaler på Kungsgatan 9,...
-
The shareholders of Virtune AB (Publ) corporate registration number 559175–2067, with registered office in Stockholm, are hereby summoned to the Annual General Meeting on Wednesday, May 20, 2026 at...
-
マレーシア・イスカンダルプテリ発, April 13, 2026 (GLOBE NEWSWIRE) -- ファー・イースト・コンソーシアム・インターナショナル・リミテッド (Far East Consortium International Limited) (「FEC」、銘柄コード: 35.HK) の子会社であるドーセット・ホスピタリティ・インターナショナル (Dorsett...
-
Austin, April 13, 2026 (GLOBE NEWSWIRE) -- The Event Stream Processing Market size reached USD 3.41 Billion in 2025 and is anticipated to touch USD 16.08 Billion by 2035, exhibiting a growth rate...
-
SHANGHÁI, April 13, 2026 (GLOBE NEWSWIRE) -- CHINAPLAS 2026 se celebrará del 21 al 24 de abril en el Centro Nacional de Exposiciones y Convenciones (NECC) de Shanghái. Bajo el tema...
-
Växjö, Sverige, 13:e april 2026 * * * JLT Mobile Computers, ledande leverantör av stryktåliga datorer för krävande miljöer, släpper idag sin årsredovisning för verksamhetsåret 2025. Periodens...
-
TANGENT met its primary and secondary endpoints with a high level of statistical significance vs. placebo at 6 months, including ORR by RECIST V1.1 and Tumor Volume Score (TVS), and clinically...
-
Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly...
-
BASEL, Switzerland, April 13, 2026 (GLOBE NEWSWIRE) -- BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and...